Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Toxicology and Applied Pharmacology
|
August 1, 1980
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride
M W Anderson, D G Hoel, N L Kaplan
Radiation Research
|
November 1, 1987
Altitude, radiation, and mortality from cancer and heart disease
C R Weinberg, K G Brown, D G Hoel
Cancer Research
|
September 1, 1986
Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments
C J Portier, J C Hedges, D G Hoel
Science (New York, N.Y.)
|
March 4, 1983
Implication of nonlinear kinetics on risk estimation in carcinogenesis
D G Hoel, N L Kaplan, M W Anderson
Radiation Research
|
May 1, 1992
Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86)
Y Shimizu, H Kato, W J Schull, et al.
Mathematical Biosciences
|
June 11, 1998
Size distributions of misrejoining DNA fragments in irradiated cells
T Radivoyevitch, D G Hoel, P Hahnfeldt, et al.
Radiation Research
|
August 1, 1982
Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants
H Kato, C C Brown, D G Hoel, et al.
IARC Scientific Publications
|
January 1, 1990
Biologically based models for risk assessment
C J Portier, D G Hoel, N L Kaplan, et al.
Cancer Research
|
September 1, 1976
Fundamental carcinogenic processes and their implications for low dose risk assessment
K S Crump, D G Hoel, C H Langley, et al.
Radiation Research
|
January 8, 1998
Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model
T Radivoyevitch, D G Hoel, A M Chen, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Toxicology and Applied Pharmacology
|
August 1, 1980
A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride
M W Anderson, D G Hoel, N L Kaplan
Radiation Research
|
November 1, 1987
Altitude, radiation, and mortality from cancer and heart disease
C R Weinberg, K G Brown, D G Hoel
Cancer Research
|
September 1, 1986
Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments
C J Portier, J C Hedges, D G Hoel
Science (New York, N.Y.)
|
March 4, 1983
Implication of nonlinear kinetics on risk estimation in carcinogenesis
D G Hoel, N L Kaplan, M W Anderson
Radiation Research
|
May 1, 1992
Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86)
Y Shimizu, H Kato, W J Schull, et al.
Mathematical Biosciences
|
June 11, 1998
Size distributions of misrejoining DNA fragments in irradiated cells
T Radivoyevitch, D G Hoel, P Hahnfeldt, et al.
Radiation Research
|
August 1, 1982
Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants
H Kato, C C Brown, D G Hoel, et al.
IARC Scientific Publications
|
January 1, 1990
Biologically based models for risk assessment
C J Portier, D G Hoel, N L Kaplan, et al.
Cancer Research
|
September 1, 1976
Fundamental carcinogenic processes and their implications for low dose risk assessment
K S Crump, D G Hoel, C H Langley, et al.
Radiation Research
|
January 8, 1998
Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model
T Radivoyevitch, D G Hoel, A M Chen, et al.
Page
of 9